CROs/Service Providers

Ewopharma acquires Immdal’s Newport Pharmaceuticals

Thursday, October 20, 2011 10:40 AM

Immdal, a privately held Irish pharmaceutical healthcare group, has sold its subsidiary Newport Pharmaceuticals to Swiss pharmaceutical company Ewopharma.

More... »

Almac expands with new facility in UK

Thursday, October 20, 2011 10:11 AM

Almac has expands its pharmaceutical development services with the creation of a new facility at our UK headquarters in Craigavon.

More... »

Quintiles acquires VCG, strengthening commercial services

Wednesday, October 19, 2011 01:01 PM

Quintiles has acquired VCG & Associates and VCG BIO. The addition of VCG strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

More... »

Quintiles acquires Outcome Sciences

Wednesday, October 19, 2011 12:52 PM

With late phase research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, a privately held outcomes research firm headquartered in Cambridge, Mass.

More... »

vRad partners with ICON Medial imaging

Monday, October 17, 2011 12:25 PM

Virtual Radiologic (vRad), a technology-enabled national radiology practice, has reported a radiology partnership with ICON Medical Imaging, the medical imaging division of ICON.

More... »

Capstone Therapeutics cuts 14 jobs

Friday, October 14, 2011 01:36 PM

Capstone Therapeutics plans to preserve cash during ongoing discussions with potential partners regarding AZX100 in dermal scarring. The company will reduce staff from its current 18 full-time employees to a core of four individuals covering required regulatory and financial functions at substantially reduced compensation.

More... »

Oncobiologics signs two agreements worth $80 million

Thursday, October 13, 2011 12:50 PM

Oncobiologics has signed two major agreements. The first is with Parilis Biopharmaceuticals, an early-stage biotech company, and involves worldwide licensing for an undisclosed biotherapeutic product. The second is with a US based pharmaceutical company to conduct research focused on solving issues related to downstream processing of monoclonal antibodies. The identity of the client firm was not disclosed due to confidentiality terms in the agreement. The combined value of the agreements to Oncobiologics totals close to $80 million.

More... »

Quintiles opens European headquarters in UK

Wednesday, October 12, 2011 10:42 AM

Quintiles has officially opened its new European headquarters in Reading, United Kingdom, bringing together employees from each of its four disciplines.

More... »

ACRO endorses Foreign Earnings Reinvestment Act

Wednesday, October 12, 2011 10:10 AM

The Association of Clinical Research Organizations (ACRO) supports the Foreign Earnings Reinvestment Act, bipartisan legislation introduced in the U.S. Senate last week by senators Kay Hagan (D-NC) and John McCain (R-AZ).

More... »

PAREXEL Academy expands to Singapore

Tuesday, October 11, 2011 01:11 PM

PAREXEL Academy, a provider of education and professional training for the biopharmaceutical industry in the field of clinical research, which is operated by PAREXEL International, has entered into an agreement with the National University of Singapore (NUS), through its National University of Singapore Academy of GxP Excellence (NUSAGE), to offer an academic program in Singapore to help meet the increasing demand for talent in the field of clinical research in the Asia region. This demand is being driven by the growing complexity and globalization of biopharmaceutical research and development.

More... »